Enteric Soft Gel Capsules Market: Introduction Transparency Market Research has published a new report titled, “Enteric soft gel capsules market”. According to the report, the global enteric soft gel capsules market was valued at US$ 210.3 Mn in 2018. It is projected to expand at a CAGR of ~7% from 2019 to 2027. In terms of application, the antibiotic & antibacterial drugs segment held major share of the global enteric soft gel capsules market in 2018. The segment is anticipated to dominate the global market during the forecast period. Adoption of preventive care measures among the population is estimated to drive the segment during the forecast period. Additionally, increase in investment by key players in the vitamins & dietary supplements and favorable trade policies for import and export of dietary supplements are anticipated to propel the vitamin & dietary supplements segment during the forecast period. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=75767 In terms of end user, the pharmaceutical industry segment is anticipated to expand at a rapid pace during the forecast period due to expansion of the pharmaceutical industry and increase in applications of capsules in different indications. Pharmaceuticals represent the largest end user of enteric capsules (soft capsule). Constant development in the pharmaceutical industry and frequent outbreaks of chronic diseases globally are key factors boosting the enteric soft gel capsules market. According to the statistics provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA), total production of pharmaceutical and biotechnological products in Europe was valued at US$ 266.5 Bn in 2012, an increase of ~67% since 2000. Request for Analysis of COVID-19 Impact on Enteric Soft Gel Capsules Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=75767 Enteric Soft Gel Capsules Market: Prominent Regions North America held second largest share of the global enteric soft gel capsules market in 2018. The enteric soft gel capsules market in the region is driven by the presence of key players, large number of research activities, and highly structured health care industry. A report published by the International Federation of Pharmaceutical Manufacturers & Associations indicated that R&D and plant investments by pharmaceutical companies in the U.S. have been increasing consistently in the last 15 years, and more than doubled the publicly funded National Institutes of Health’s (NIH) expenditure in 2014. Europe held the second-largest share of the global enteric soft gel capsules market in 2018. Expansion of the enteric soft gel capsules market in the region can be attributed to increase in investments by key players in pharmaceuticals and life sciences industries, and government intervention in the field of environmental control and food safety. Asia Pacific accounted for a significant share of the global enteric soft gel capsules market in 2018. The market in the region is expected to expand at a rapid pace during the forecast period. Increase in investments by key players in manufacturing of drugs and expansion of the nutraceutical industry are likely to drive the enteric soft gel capsules market in Asia Pacific. Emerging economy, government